1 Economics of Innovation Patents Manuel Trajtenberg 2005
Jan 12, 2016
1
Economics of Innovation
Patents
Manuel Trajtenberg2005
2
What are patents all about?•A patent is a legal document that grants monopoly rights over a specific innovation for a specified period of time (~ 20 years).
• Why? To provide incentives to innovate: if inventions could be copied, nobody will incur the fix costs of developing it.
• So important that specified in the US Constitution.
•Patents involve a deal: monopoly rights in exchange for disclosure – that further promotes innovation.
•As R&D and innovation become more important in the industrialized world, patent protection gains in stature.
3
Patents as mechanism of appropriability
• Innovation: creation of new Knowledge
• Nice/nasty property of Knowledge: it leaks out easily!
• Costs of copying knowledge usually very low
• Hence need protection in order to reap benefits from innovation =>
Need appropriability mechanisms
4
Other mechanisms of appropriability
• Secrecy
• Lead Times
• Monopoly power in the field – barriers to entry
Patents – important in pharmaceuticals and chemicals, less in other industries
5
Additional roles of patents
• Tool for mutual deterrence
• Tool for transfer/trade in technology, e.g. from Universities, from
individual inventors/start ups.
6
Patent Policy
• Scope of what’s patentable: business methods, gene sequences…
• “Size” (breath) of patents
• How/when to allow for opposition/ appeals?
• Whether and when to disclose applications.
7
International Issues
• Harmonization (e.g. first to file vs. first to invent)
• Pharmaceutical patents in third world countries.
• Enforcement.
8
Patents as depositories of wealth of information on innovation
• Very detailed information, millions of patents
• Can study countries, firms, inventors;
• Can study links over time and across geography and institutions.
(see front page of patent)
9
Front page of patent (partial)United States Patent 6,539,988
Pressurized container adapter for charging automotive systems
Inventors:
Cowan; David M. (Brooklyn, NY); Schapers; Jochen (New York, NY); Trachtenberg; Saul (New York, NY); Nikolayev; Nikolay V. (Flushing, NY)
Assignee: Interdynamics, Inc. (Brooklyn, NY)
Filed: December 28, 2001
Current U.S. Class:141/67; 137/614.04; 141/351; 251/149.1
Intern'l Class: B65B
Primary Examiner: Douglas; Steven O. Attorney, Agent or Firm: Levisohn, Lerner, Berger & Langsam LLP
10
Front page – cont.References Cited
3131733May., 1964Monahon.
3448779Jun., 1969Horwitt.
3907012Sep., 1975Burke.
3976110Aug., 1976White.
4644982Feb., 1987Hatch.
4903741Feb., 1990Ibanez141/350.
4995417Feb., 1991Naku.
5248125Sep., 1993Fritch et al.
5609195Mar., 1997Stricklin et al.141/346.
5626173May., 1997Groult.
6079444Jun., 2000Harris et al.137/614.
6296228Oct., 2001Knowles et al.
6360795Mar., 2002Bothe et al.141/346.
11
Patent Citations: Spillovers, Importance
Compaq4/1995
TX
Intel11/1996
AZ IBM3/1997
TX, FL
Compaq7/1995
TX
Compaq10/1998
CA
spillovers
importance
“Self-citations”
12
Number of USPTO Patents by Application Year
0
20,000
40,000
60,000
80,000
100,000
120,000
140,000
160,000
13
US patents granted, by grant year Pre 199019992000200120022003All Years
Total, U.S. And Foreign Origin 18155311534861574941660371673331690283583813
-- Subtotal -- U.S. Origin 118212483906850688760586972879012132534
-- Subtotal -- Foreign Origin 63340769580724267843280361811271451279
JAPAN 1843483110431295332243485935517556335
GERMANY 146010933710235112591128011444265313
UK 7082535723667396538373627113109
FRANCE 5472538203819404140353869101163
CANADA 311443226341936063431342667753
SWITZERLAND 313861279132214201364130848728
TAIWAN 23413693466753715431529840746
ITALY 196001492171417091751172239328
SWEDEN 196811401157717411675152134800
NETHERLANDS 173531247124113321391132531978
SOUTH KOREA 5993562331435383786394429437
AUSTRALIA 640270770587585990014725
BELGIUM 656764869471872262213728
AUSTRIA 659547950558953059212476
ISRAEL 28777437839701040119311364
14
Distribution of Patents by Technological Categories – Shares
0%
5%
10%
15%
20%
25%
30%
Application Year
Chemical Cmp&Cmm Drgs&Med Elec Mech Others
15
Citations Received by Technological Categories
0
2
4
6
8
10
12
14
Application Year
Me
an
Cit
ati
on
Chemical Cmp&Cmm Drgs&Med Elec Mech Others
16
Israeli Patents in the USby Application Year
0
100
200
300
400
500
600
700
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
Application Year
Pat
ents
Iss
ued
1983 : 151
1987 : 295
1991 : 312
1995 : 613
17
Patents per Capita: Israel vs. the G7
0
5
10
15
20
25
30
19701971
19721973
19741975
19761977
19781979
19801981
19821983
19841985
19861987
19881989
19901991
19921993
19941995
19961997
(patents per 100,000 population)
USAJapan
GermanyIsrael
18
Patents Per Capita: Israel vs. Reference Group
0
2
4
6
8
10
12
Pat
/ Popu
latio
n
Israel
Finland
Ireland
New Zealand
Spain
(patents per 100,000 population)
Israel
Finland
19
Patents Per Capita: Israel vs. the NIC
0
2
4
6
8
10
12
14
19701971
19721973
19741975
19761977
19781979
19801981
19821983
19841985
19861987
19881989
19901991
19921993
19941995
19961997
Pat
/ Popu
lati
on
Israel
Hong Kong
Singapore
South Korea
Taiwan
(patents per 100,000 population)
Israel
TaiwanSouth Korea
20
US vs. Israel Patents: Technological Categories
0%
5%
10%
15%
20%
25%
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
Mechanical Chemical Drugs & Medicine Computers &Communications
0%
5%
10%
15%
20%
25%
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
US Distribution Israeli Distribution
21
Distribution of Israeli Assignees Types3-year moving average
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Corp
Gov
Unv
22
Relative "Importance" of Israeli Patents by Tech Category(from regression results)
-1.5
-1
-0.5
0
0.5
1
1.5
USA
Reference Group
23
Spillovers and geography
QJE 1993
24
The Sample
25
Results – country localization
26
Results: State and SMSA
27
The “fading” over time of geographic localization
28
29
Patents in CT
30
31
Patents and R&D